Literature DB >> 11880340

eFGF is required for activation of XmyoD expression in the myogenic cell lineage of Xenopus laevis.

Malcolm E Fisher1, Harry V Isaacs, Mary E Pownall.   

Abstract

This paper addresses the molecular mechanisms that regulate the transcriptional activation of the myogenic regulatory factor XmyoD in the skeletal muscle lineage of Xenopus laevis. Using antisense morpholino oligonucleotide-mediated inhibition, we show that the signalling molecule embryonic fibroblast growth factor (eFGF), which is the amphibian homologue of FGF4, is necessary for the initial activation of XmyoD transcription in myogenic cells. We demonstrate that eFGF can activate the expression of XmyoD in the absence of protein synthesis, indicating that this regulation is direct. Our data suggest that regulation of XmyoD expression may involve a labile transcriptional repressor. In addition, we show that eFGF is itself an immediate early response to activin, a molecule that mimics the endogenous mesoderm-inducing signal. We propose a model for the regulation of XmyoD within the early mesoderm, and discuss the relevance that these findings have for the understanding of myogenic specification in higher vertebrates.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11880340     DOI: 10.1242/dev.129.6.1307

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  13 in total

Review 1.  FGF signalling: diverse roles during early vertebrate embryogenesis.

Authors:  Karel Dorey; Enrique Amaya
Journal:  Development       Date:  2010-11       Impact factor: 6.868

2.  The role of FGF signaling in the establishment and maintenance of mesodermal gene expression in Xenopus.

Authors:  Russell B Fletcher; Richard M Harland
Journal:  Dev Dyn       Date:  2008-05       Impact factor: 3.780

3.  Regulation of early Xenopus development by ErbB signaling.

Authors:  Shuyi Nie; Chenbei Chang
Journal:  Dev Dyn       Date:  2006-02       Impact factor: 3.780

4.  The splicing factor PQBP1 regulates mesodermal and neural development through FGF signaling.

Authors:  Yasuno Iwasaki; Gerald H Thomsen
Journal:  Development       Date:  2014-09-10       Impact factor: 6.868

5.  BMP inhibition initiates neural induction via FGF signaling and Zic genes.

Authors:  Leslie Marchal; Guillaume Luxardi; Virginie Thomé; Laurent Kodjabachian
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-28       Impact factor: 11.205

6.  Signals and myogenic regulatory factors restrict pax3 and pax7 expression to dermomyotome-like tissue in zebrafish.

Authors:  Christina L Hammond; Yaniv Hinits; Daniel P S Osborn; James E N Minchin; Gianluca Tettamanti; Simon M Hughes
Journal:  Dev Biol       Date:  2006-10-10       Impact factor: 3.582

7.  A zebrafish embryo culture system defines factors that promote vertebrate myogenesis across species.

Authors:  Cong Xu; Mohammadsharif Tabebordbar; Salvatore Iovino; Christie Ciarlo; Jingxia Liu; Alessandra Castiglioni; Emily Price; Min Liu; Elisabeth R Barton; C Ronald Kahn; Amy J Wagers; Leonard I Zon
Journal:  Cell       Date:  2013-11-07       Impact factor: 41.582

8.  Cyclin E is recruited to the nuclear matrix during differentiation, but is not recruited in cancer cells.

Authors:  Jennifer Munkley; Nikki A Copeland; Victoria Moignard; John R P Knight; Erin Greaves; Simon A Ramsbottom; Mary E Pownall; Jennifer Southgate; Justin F-X Ainscough; Dawn Coverley
Journal:  Nucleic Acids Res       Date:  2010-11-24       Impact factor: 16.971

9.  Characterisation of the fibroblast growth factor dependent transcriptome in early development.

Authors:  Peter A Branney; Laura Faas; Sarah E Steane; Mary Elizabeth Pownall; Harry V Isaacs
Journal:  PLoS One       Date:  2009-03-31       Impact factor: 3.240

10.  Mef2d acts upstream of muscle identity genes and couples lateral myogenesis to dermomyotome formation in Xenopus laevis.

Authors:  Bruno Della Gaspera; Anne-Sophie Armand; Sylvie Lecolle; Frédéric Charbonnier; Christophe Chanoine
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.